How common is severe pulmonary hypertension after pediatric cardiac surgery?

L Lindberg1, A K Olsson, P Jögi

  • 1Division of Heart and Lung, Section of Pediatric Cardiac Surgery, University Hospital, Lund, Sweden. larsolavlindberg@hotmail.com

Insights

Severe pulmonary hypertension after pediatric cardiac surgery occurred in 2% of cases. Most children experienced favorable outcomes with conventional treatment, suggesting improved surgical care and early interventions contribute to better results.

Area of Science:

  • Pediatric Cardiology
  • Cardiothoracic Surgery
  • Critical Care Medicine

Background:

  • Pulmonary hypertension is a significant risk factor for morbidity and mortality in children undergoing cardiac surgery.
  • Defining and identifying severe pulmonary hypertension post-cardiac surgery is crucial for patient outcomes.

Purpose of the Study:

  • To determine the incidence and outcomes of severe pulmonary hypertension (pulmonary to systemic arterial pressure ratio >= 1.0) after pediatric cardiac surgery.
  • To analyze factors associated with severe pulmonary hypertension in this population.

Main Methods:

  • Retrospective review of cardiothoracic surgery patients younger than 18 years (1994-1998).
  • Identification of severe pulmonary hypertension using pulmonary artery catheter data, mechanical ventilation duration, and perioperative mortality.
  • Analysis of intraoperative and postoperative hemodynamic measurements and echocardiographic studies.

Main Results:

  • Severe pulmonary hypertension was identified in 2% (27/1349) of pediatric cardiac surgery patients, with a median age of 4.2 months.
  • Mortality within 30 days was 7.4% (2/27), and within one year was 11% (3/27).
  • Complete atrioventricular septal defects and Down syndrome were associated with higher incidence of severe pulmonary hypertension.

Conclusions:

  • Severe postoperative pulmonary hypertension occurred in 2% of pediatric cardiac procedures.
  • Most cases were managed successfully with conventional treatments, leading to favorable outcomes.
  • Improved perioperative care and early correction strategies may explain the lower incidence compared to previous studies.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...